Corona vaccine: German head of research gives harsh forecast - "Pandemic will not be defeated next year"

The development of corona vaccines is in full swing worldwide.

The participant of a pharmaceutical company explained how it currently looks.

• Scientists

  around the

  world are researching the

  coronavirus *

  and trying

  to develop

  a

  vaccine *

  .

• The French company Sanofi-Aventis is also participating in the global race against the virus.

• The Germany head for research and development explains why it is not a race and why research is being pulled together.

• Here you will find the Corona news from Germany and a map of the current infection situation.

Munich / Frankfurt - Since the

around the world, scientists * have been researching the development of an effective

at full

.

The pharmaceutical company

working on it.

In an interview with

, the head of

research and development for Germany explained

which vaccines could be available, how safe they are and whether he would have himself tested.

He also described that one thing in the corona pandemic was different than usual.

Corona vaccine: three types are being worked on

In principle, three types of vaccine would be tested, as

explains:

Even if there are different experiences, Maas makes no difference for himself personally: “I would be vaccinated with all three types.

"With regard to the plans for a dead vaccine, Maas said:" If we receive approval, Sanofi will probably bring such a vaccine onto the market in the summer of next year. "An insulin filling plant in Frankfurt is already being converted for this purpose.

“We will manufacture 200 million cans per year there,” says the pharmaceutical entrepreneur.

A lot of money has to be invested in the development of a vaccine without any certainty whether the substance will even be approved by the authorities.

The

that enter the company here Maas called

.

"So far, Sanofi has invested a three-digit million sum in research, development and testing of a vaccine without knowing whether it will work," says Maas.

Corona vaccines should remain affordable: "No company will be able to make a profit"

Still, it would regulate that prices would not go so high and that a company could make extreme profits from the vaccines.

“Governments everywhere will ensure that the vaccine

remains

and no company will be able to make a profit here.

I expect that the price for one dose will be affordable for everyone, including the poorer countries, ”Maas explained.

Video: Corona vaccine: Biontech boss Ugur Sahin gives hope

Even if there is great economic potential in vaccine development, the race is more collegial than hostile.

“The enemy is not the competitor, but the virus.

Everyone sees it that way.

The science and business community works together excellently across borders and continents.

The authorities and politics are also pulling along.

Everyone knows that no one can produce eight billion vaccine doses alone, ”said Maas, describing the“ unique ”situation in an interview with

.

Corona: far-reaching immunization not yet foreseeable - "a gigantic logistical undertaking"

While the prospects for a

are good right now, that doesn't mean the pandemic will be over next year.

“If the vaccine is there, it is very good, but it will not improve our situation immediately.

It then has to be mass produced, bottled and distributed.

We need four to eight billion doses of vaccine worldwide, depending on whether a simple vaccination is sufficient or whether it has to be repeated.

”says Maas, describing the challenge.

Nonetheless,

the population appears to be the only long-term effective means of ending the pandemic.

The worldwide cooperation gives hope for a cooperative, international strategy.